Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Understanding your coverage, copay, and prior authorization requirements ahead of time eliminates delays when you need them most
Antiviral asset bictegravir (GS-9883), an investigational integrase strand transfer inhibitor achieved proof-of-concept based on data from four preclinical and Phase I studies evaluating the antiviral potency, resistance profile, pharmacokinetics and safety
This is achievable but requires intention
FSA & HSA ELIGIBLE 4.9 Avg
US$ 20.23
US$ 20.13
US$ 28.10
US$ 27.02
US$ 23.19
